← Leaderboards
Vance G Fowler
Duke University
$95,483,666
Attributed
$180,950,651
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $20.5M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$180,950,651 · 9
By mechanism
UM1$166,501,529 · 1
R01$11,703,201 · 3
K24$1,557,506 · 1
R56$674,578 · 1
K23$497,837 · 1
R13$16,000 · 2
Top collaborators
- Henry F Chambers14 shared
- William K. Scott5 shared
- Brian Patrick Conlon1 shared
Most similar at Duke University
Same institution · by research overlap
- Henry F Chambers$93,384,193
- Maria Schumacher$11,809,128
- Emmanuel B Walter$22,544,318
- Vance Fowler$19,614,788
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesResearch PersonnelInfectionStaphylococcus AureusPredispositionBacteremiaProgramsPathogenCommunitiesGenetic DeterminismGeneticBiobankClinical ResearchBaseBacteriaSepsisMentorsGenotypeMethicillin Resistant Staphylococcus AureusPathogenesisSamplingMedicalResearch InfrastructureAntibiotics
Grant awards (49)
Antibacterial Resistance Leadership Group (ARLG)$14,396,446
UM1 · FY2025 · AI · contact PI
HLA Fine Mapping to Elucidate S. aureus Susceptibility$611,609
R01 · FY2025 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$14,519,432
UM1 · FY2024 · AI · contact PI
HLA Fine Mapping to Elucidate S. aureus Susceptibility$776,292
R01 · FY2024 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$14,675,641
UM1 · FY2023 · AI · contact PI
HLA Fine Mapping to Elucidate S. aureus Susceptibility$782,369
R01 · FY2023 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$14,729,883
UM1 · FY2022 · AI · contact PI
HLA Fine Mapping to Elucidate S. aureus Susceptibility$780,551
R01 · FY2022 · AI · contact PI
The contribution of respiratory burst to antibiotic failure in Staphylococcus aureus bacteremia$674,578
R56 · FY2022 · AI
Antibacterial Resistance Leadership Group (ARLG)$19,709,872
UM1 · FY2021 · AI · contact PI
HLA Fine Mapping to Elucidate S. aureus Susceptibility$807,042
R01 · FY2021 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$14,943,650
UM1 · FY2020 · AI · contact PI
Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria$176,807
K24 · FY2020 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$56,350
UM1 · FY2020 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$19,183,975
UM1 · FY2019 · AI · contact PI
Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria$176,807
K24 · FY2019 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$10,000,000
UM1 · FY2018 · AI · contact PI
Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria$176,807
K24 · FY2018 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$8,000,000
UM1 · FY2017 · AI · contact PI
Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria$176,807
K24 · FY2017 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$10,000,000
UM1 · FY2016 · AI · contact PI
Host Susceptibility to S. aureus$696,563
R01 · FY2016 · AI · contact PI
Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria$152,245
K24 · FY2016 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$11,286,280
UM1 · FY2015 · AI · contact PI
Host Susceptibility to S. aureus$712,006
R01 · FY2015 · AI · contact PI
Mentoring Clinical and Translational Patient-Oriented Research in Staphylococci$138,001
K24 · FY2015 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$13,000,000
UM1 · FY2014 · AI · contact PI
Host Susceptibility to S. aureus$702,570
R01 · FY2014 · AI · contact PI
Mentoring Clinical and Translational Patient-Oriented Research in Staphylococci$138,832
K24 · FY2014 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$2,000,000
UM1 · FY2013 · AI · contact PI
Host Susceptibility to S. aureus$662,826
R01 · FY2013 · AI · contact PI
Mentoring Clinical and Translational Patient-Oriented Research in Staphylococci$139,656
K24 · FY2013 · AI · contact PI
2013 Staphylococcal Diseases Gordon Research Conference and Gordon Research Semin$6,000
R13 · FY2013 · AI · contact PI
Host Susceptibility to S. aureus$715,101
R01 · FY2012 · AI · contact PI
Mentoring Clinical and Translational Patient-Oriented Research in Staphylococci$140,390
K24 · FY2012 · AI · contact PI
Host Susceptibility S. aureus$638,020
R01 · FY2011 · AI · contact PI
Mentoring Clinical and Translational Patient-Oriented Research in Staphylococci$141,154
K24 · FY2011 · AI · contact PI
2011 Staphyloccocal Diseases Gordon Research Conference$10,000
R13 · FY2011 · AI · contact PI
Host Susceptibility S. aureus$644,439
R01 · FY2010 · AI · contact PI
Host Susceptibility S. aureus$631,990
R01 · FY2009 · AI · contact PI
Host Susceptibility S. aureus$847,582
R01 · FY2008 · AI · contact PI
Host Susceptibility S. aureus$606,599
R01 · FY2007 · AI · contact PI
Virulence determinants in S. aureus bacteremia$366,839
R01 · FY2006 · AI · contact PI
Virulence determinants in S. aureus bacteremia$367,199
R01 · FY2005 · AI
Virulence determinants in S. aureus bacteremia$353,604
R01 · FY2004 · AI
UNDERSTANDING THE PATHOGENESIS OF STAPHYLOCOCCUS AUREUS$125,375
K23 · FY2003 · AI
UNDERSTANDING THE PATHOGENESIS OF STAPHYLOCOCCUS AUREUS$125,375
K23 · FY2002 · AI
UNDERSTANDING THE PATHOGENESIS OF STAPHYLOCOCCUS AUREUS$125,375
K23 · FY2001 · AI
UNDERSTANDING THE PATHOGENESIS OF STAPHYLOCOCCUS AUREUS$121,712
K23 · FY2000 · AI